Cited by 383PI3K/AKT/mTOR signaling in cancerMetabolism, Diabetes, and CancerLipid metabolism and biosynthesis

The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes

Open access
Berwick, Daniel C., Hers, Ingeborg, Heesom, Kate J., Moule, S. Kelly, Tavareá, Jeremy M.·2002·Journal of Biological Chemistry

Abstract

Protein kinase B (Akt) plays a central role in cellular regulation, although many of the physiologically relevant substrates for the kinase remain to be identified. In this study, we have isolated a protein from primary epididymal adipocytes with an apparent molecular weight of 125,000. This protein exhibited immunoreactivity, in an insulin-dependent manner, with a phosphospecific antibody raised against the protein kinase B substrate consensus sequence RXRXX(pS/pT) as well as a phosphospecific antibody that recognizes serine 21/9 of GSK-3alpha/beta. MALDI-TOF mass spectrometry revealed the protein to be ATP-citrate lyase, suggesting that the two phosphospecific antibodies recognize phosphoserine 454, a previously reported insulin- and isoproterenol-stimulated ATP-citrate lyase phosphorylation site. Indeed, both insulin and isoproterenol stimulated the phosphorylation of this protein on the site recognized by the phosphospecific antibodies in a wortmannin-sensitive and -insensitive manner, respectively. In addition, transient expression of a constitutively active protein kinase B in primary adipocytes mimicked the effect of insulin on ATP-citrate lyase phosphorylation. Furthermore, ATP-citrate lyase was phosphorylated in vitro by recombinant protein kinase B on the same site. Taken together, these results demonstrate that serine 454 of ATP-citrate lyase is a novel and major in vivo substrate for protein kinase B.

Integrity signals

Registry

Crossref · 10.1074/jbc.m204681200

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The PI3K-AKT signaling pathway mediates both the generation and cytosolic export of glucose-derived citrate, whereas AKT-mediated phosphorylation of ACL enhances its catalytic activity.

    “The PI3K–AKT signaling pathway mediates both the generation and cytosolic export of glucose-derived citrate, whereas AKT-mediated phosphorylation of ACL enhances its catalytic activity (190).”
  • PI3K/Akt activation allows a cell to expand its cytosolic acetyl-CoA pool, a substrate for de novo fatty acid biosynthesis.

    “In particular, PI3K/Akt activation allows a cell to expand its cytosolic pool of acetyl-CoA, a substrate for the de novo biosynthesis of fatty acids.”

    From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Berwick et al., 2002

  • Akt activates ACLY, which cleaves TCA-derived citrate into acetyl-CoA and oxaloacetate.

    “To this end, Akt activates the ATP-citrate lyase (ACLY) enzyme, which catalyzes cytosol-localized cleavage of the TCA cycle-derived citrate into acetyl-CoA and oxaloacetate (Bauer et al., 2005; Berwick et al., 2002).”

    From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Berwick et al., 2002

The citation lists haven’t been fetched yet

References 46 · Cited by 383

Authors
Berwick, D. C., Hers, I., Heesom, K. J., Moule, S. K., & Tavareá, J. M.
Affiliations
University of Bristol (GB)
Corresponding author
Tavareá, Jeremy M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2002-09
Volume
277
Issue
37
Pages
33895-33900
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2046976278
Cited by
383
References
46
Citations by year
2026: 7 · 2025: 14 · 2024: 17 · 2023: 22 · 2022: 29 · 2021: 25 · 2020: 22 · 2019: 18 · 2018: 18 · 2017: 24 · 2016: 21 · 2015: 10 · 2014: 21 · 2013: 14 · 2012: 22
FWCI
3.24
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Bristol Research (University of Bristol) (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Open Research Online - ORO (The Open University) (submittedVersion)
  • Explore Bristol Research (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
ATP citrate lyase, Akt, adipocytes, insulin signaling, isoproterenol, substrate identification, phospho-specific antibodies
MeSH terms
Amino Acid Sequence, Animals, ATP Citrate (pro-S)-Lyase, Insulin, Molecular Sequence Data, Molecular Weight, Phosphorylation, Proto-Oncogene Proteins, Transfection, Rats, Wistar, Protein Serine-Threonine Kinases, Adipocytes, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins c-akt, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review